With the Launch of Covid-19 Antibody Testing announced in June, Major New Contract Signed, it has been a blistering start to the month.
Cathal Friel, Executive Chairman gave this exclusive interview and he is confident that further news is just around the corner.
Open Orphan plc (ORPH) is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses; hVIVO and Venn Life Sciences and has offices in London, Dublin, Paris, and the Netherlands. Open Orphan is led by a management team with deep industry and financial experience
Cathal Friel, Executive Chairman of Open Orphan, said:
“hVIVO is a world-class company with best in class scientists and facilities. We are very excited to be offering this service and I am confident our work will help large companies and clinics in the UK test their staff and patients to ensure the safety of all employees. These are run from its 24-bedroom quarantine clinic in London, with an onsite virology laboratory.
See www.flucamp.com to see how volunteers are managed.
Company Website www.openorphan.com
Twitter @OpenOrphan
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned
